Neuronetics (STIM) Depreciation & Amortization (CF) (2017 - 2026)

Neuronetics' (STIM) quarterly Depreciation & Amortization (CF) came in at $745000.0 in Q1 2026, down 18.22% year-on-year from $911000.0 in Q1 2025, and down 2.87% on a QoQ basis from $767000.0 in Q4 2025.

Neuronetics (STIM) Depreciation & Amortization (CF) (2017 - 2026) Analysis & Trends

Neuronetics (STIM) has 10 years of Depreciation & Amortization (CF) data on file, last reported at $745000.0 in Q1 2026.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 18.22% year-over-year to $745000.0 in Q1 2026; TTM through Mar 2026 was $3.3 million, a 36.1% increase from a year earlier, with the FY2025 full-year figure at $3.5 million, up 67.15% from the prior year.
  • Depreciation & Amortization (CF) for Q1 2026 stood at $745000.0, down from $767000.0 in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for STIM reached as high as $911000.0 in Q1 2025 and fell as low as $319000.0 in Q1 2022.
  • Historically, Depreciation & Amortization (CF) has averaged $584529.4 across 5 years, with a median of $516000.0 in 2023.
  • Across the five-year window, Depreciation & Amortization (CF) jumped 106.85% in 2022 and dropped 18.22% in 2026, its largest moves.
  • Year by year, Depreciation & Amortization (CF) stood at $604000.0 in 2022, then retreated by 16.72% to $503000.0 in 2023, then dropped by 11.33% to $446000.0 in 2024, then soared by 71.97% to $767000.0 in 2025, then declined by 2.87% to $745000.0 in 2026.
  • Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $745000.0 in Q1 2026, $767000.0 in Q4 2025, and $886000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 381.00 Mn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 120.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 716.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 351.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 40.90 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 67.10 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 310.25 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 78.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Neuronetics 130.83 Mn 128.62 Mn 16.15 Mn 745,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 745,000.00
Mar 31, 2026 745,000.00
Dec 31, 2025 767,000.00
Dec 31, 2025 767,000.00
Sep 30, 2025 886,000.00
Sep 30, 2025 886,000.00
Jun 30, 2025 901,000.00
Jun 30, 2025 901,000.00
Mar 31, 2025 911,000.00
Mar 31, 2025 911,000.00
Dec 31, 2024 446,000.00
Dec 31, 2024 446,000.00
Sep 30, 2024 512,000.00
Sep 30, 2024 512,000.00
Jun 30, 2024 555,000.00
Jun 30, 2024 555,000.00
Mar 31, 2024 560,000.00
Mar 31, 2024 560,000.00
Dec 31, 2023 503,000.00
Dec 31, 2023 503,000.00